| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 6.85▼ | 6.85▼ | 6.85▼ | 6.93▼ | 6.65▲ |
| MA10 | 6.85▼ | 6.85▼ | 6.89▼ | 6.63▲ | 6.31▲ |
| MA20 | 6.85▼ | 6.88▼ | 6.97▼ | 6.60▲ | 6.07▲ |
| MA50 | 6.86▼ | 7.02▼ | 6.75▲ | 6.27▲ | 5.89▲ |
| MA100 | 6.88▼ | 6.71▲ | 6.59▲ | 5.91▲ | 5.57▲ |
| MA200 | 6.97▼ | 6.61▲ | 6.51▲ | 5.80▲ | 5.45▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | 0.001▲ | -0.034▼ | 0.039▲ | 0.092▲ |
| RSI | 48.864▼ | 44.928▼ | 47.319▼ | 57.998▲ | 57.904▲ |
| STOCH | 47.985 | 36.997 | 24.573 | 63.605 | 63.953 |
| WILL %R | -64.286 | -74.510 | -86.170▼ | -48.955 | -34.150 |
| CCI | -11.667 | -10.839 | -41.641 | 69.090 | 129.787▲ |
|
Tuesday, August 19, 2025 12:34 PM
Abeona Therapeutics Inc. ( NASDAQ: ABEO) Q2 2025 Earnings Conference Call August 14, 2025 8:30 AM ET ...
|
|
Monday, August 18, 2025 10:46 AM
ABEO READ THE FULL ABEO RESEARCH REPORT Business Update Commercial Launch of Zevaskyn® On-Track; First Patient to be Treated in 3Q25 Abeona Therapeutics, Inc. (NASDAQ:ABEO) is continuing to advance ...
|
|
Friday, August 15, 2025 01:36 PM
FDA's approval of Abeona Therapeutics Inc.'s Zevaskyn & $155M PRV sale strengthen financials. Click for my updated look at ABEO stock post earnings.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 19/08/25 | 6.86 | 6.95 | 6.78 | 6.84 | 860,173 |
| 18/08/25 | 7.11 | 7.26 | 6.78 | 6.91 | 949,984 |
| 15/08/25 | 7.35 | 7.5401 | 7.11 | 7.13 | 1,154,210 |
| 14/08/25 | 6.85 | 7.27 | 6.7662 | 7.23 | 1,569,022 |
| 13/08/25 | 6.41 | 6.72 | 6.32 | 6.56 | 828,996 |
| 12/08/25 | 6.30 | 6.45 | 6.205 | 6.38 | 758,993 |
| 11/08/25 | 6.26 | 6.395 | 6.215 | 6.28 | 595,662 |
| 08/08/25 | 6.27 | 6.325 | 6.11 | 6.26 | 414,488 |
| 07/08/25 | 6.37 | 6.42 | 6.215 | 6.27 | 442,869 |
| 06/08/25 | 6.47 | 6.48 | 6.30 | 6.39 | 424,454 |
|
|
||||
|
|
||||
|
|